NASDAQ:GCTK

GlucoTrack (GCTK) Stock Price, News & Analysis

GlucoTrack logo
$0.20 +0.01 (+4.21%)
As of 11/18/2026 02:54 PM Eastern

About GlucoTrack Stock (NASDAQ:GCTK)

Advanced

Key Stats

Today's Range
$0.19
▼
$0.24
50-Day Range
$0.19
▼
$6.46
52-Week Range
$0.19
▼
$207.00
Volume
9,794 shs
Average Volume
688,770 shs
Market Capitalization
$234.43 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

GlucoTrack, Inc. is a medical technology company developing blood glucose monitoring solutions for people with diabetes. Its work has included the GlucoTrack device, a non-invasive monitor designed to estimate glucose levels using a sensor worn on the earlobe.

The company has also focused on developing an implantable continuous glucose monitoring system. This technology is intended to track glucose levels continuously, offering an alternative to periodic testing; it remains a development effort rather than a widely established commercial product.

AI Generated. May Contain Errors.

GlucoTrack Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
3rd Percentile Overall Score

GCTK MarketRank™: 
0.16648396821 of 5 stars

GlucoTrack scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    GlucoTrack has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    GlucoTrack has only been the subject of 1 research reports in the past 90 days.

  • Read more about GlucoTrack's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of GlucoTrack is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of GlucoTrack is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    GlucoTrack has a P/B Ratio of 0.00. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    12.99% of the float of GlucoTrack has been sold short.
  • Short Interest Ratio / Days to Cover

    GlucoTrack has a short interest ratio ("days to cover") of 0.55, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in GlucoTrack has recently increased by 18.53%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    GlucoTrack does not currently pay a dividend.

  • Dividend Growth

    GlucoTrack does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 1 news article for GlucoTrack this week, compared to 2 articles on an average week.
  • Search Interest

    Only 1 people have searched for GCTK on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added GlucoTrack to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, GlucoTrack insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    5.90% of the stock of GlucoTrack is held by insiders.

  • Percentage Held by Institutions

    10.92% of the stock of GlucoTrack is held by institutions.

  • Read more about GlucoTrack's insider trading history.
Receive GCTK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GlucoTrack and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GCTK Stock News Headlines

GlucoTrack Delays Quarterly Filing Amid Valuation Review
GlucoTrack (NASDAQ:GCTK) Stock Falls 5.9% - What's Next?
Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.tc pixel
GlucoTrack, Inc.(OTCPK:GCTK) dropped from S&P TMI Index
Glucotrack, Inc. Announces Reverse Stock Split
Glucotrack Announces 1-for-2 Reverse Stock Split
See More Headlines

GCTK Stock Analysis - Frequently Asked Questions

GlucoTrack's stock was trading at $116.10 at the beginning of 2026. Since then, GCTK stock has decreased by 99.8% and is now trading at $0.1980.

GlucoTrack, Inc. (NASDAQ:GCTK) issued its quarterly earnings data on Thursday, August, 14th. The company reported ($288.60) earnings per share (EPS) for the quarter.

Shares of GlucoTrack reverse split on the morning of Tuesday, February 4th 2025.The 1-20 reverse split was announced on Thursday, January 30th 2025. The number of shares owned by shareholders was adjusted after the market closes on Monday, February 3rd 2025. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of GCTK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that GlucoTrack investors own include NVIDIA (NVDA), Tesla (TSLA), Broadcom (AVGO), Compass Therapeutics (CMPX), Cisco Systems (CSCO), Alphabet (GOOG) and Intel (INTC).

Company Calendar

Today
11/18/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:GCTK
CIK
1506983
Employees
5
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($275.26)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$19.39 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-2,135.52%
Return on Assets
-290.22%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.46
Quick Ratio
0.46

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$83.85 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
1,184,000
Free Float
1,114,000
Market Cap
$234.43 thousand
Optionable
Not Optionable
Beta
0.90
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NASDAQ:GCTK) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners